相似文献
1
Antisense technology for cancer therapy: does it make sense?
Br J Cancer. 1993 May;67(5):869-76. doi: 10.1038/bjc.1993.164.
2
Antisense treatment of viral infection.
Adv Virus Res. 1994;44:267-303. doi: 10.1016/s0065-3527(08)60331-0.
3
Antisense tumor therapy (a dream under construction).
In Vivo. 1994 Nov-Dec;8(5):781-6.
4
Making sense of antisense.
Trends Mol Med. 2001 Oct;7(10):430-1. doi: 10.1016/s1471-4914(01)02155-4.
5
[The application of antisense technology in ophthalmology].
Yan Ke Xue Bao. 1998 Jun;14(2):108-15.
6
Antisense DNA and RNA strategies: new approaches to therapy.
J R Coll Physicians Lond. 1994 Nov-Dec;28(6):507-11.
7
Molecular therapeutic strategies in hepatitis B virus infection.
Clin Investig. 1994 Oct;72(10):737-41. doi: 10.1007/BF00180539.
8
Antisense and sensibility.
Nat Biotechnol. 2002 Feb;20(2):121-4. doi: 10.1038/nbt0202-121.
9
Antisense strategies in degenerative joint diseases: sense or nonsense?
Adv Drug Deliv Rev. 2006 May 20;58(2):285-99. doi: 10.1016/j.addr.2006.01.010. Epub 2006 Feb 14.
10
Antisense DNA and RNA agents against picornaviruses.
Front Biosci. 2008 May 1;13:4707-25. doi: 10.2741/3034.
引用本文的文献
1
Terpene-loaded Liposomes and Isopropyl Myristate as Chemical Permeation Enhancers Toward Liposomal Gene Delivery in Lung Cancer cells; A Comparative Study.
Iran J Pharm Res. 2016 Summer;15(3):261-267.
2
Preparation and in-vitro Evaluation of an Antisense-containing Cationic Liposome against Non-small Cell Lung Cancer: a Comparative Preparation Study.
Iran J Pharm Res. 2013 Winter;12(Suppl):3-10.
3
Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells.
Br J Cancer. 2002 Oct 7;87(8):898-904. doi: 10.1038/sj.bjc.6600563.
4
Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA--in vitro and in vivo studies.
J Cancer Res Clin Oncol. 1997;123(1):25-33. doi: 10.1007/BF01212611.
5
Molecular oncology in pancreatic cancer.
J Mol Med (Berl). 1996 Jun;74(6):313-20. doi: 10.1007/BF00207508.
6
A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.
Nucleic Acids Res. 1995 Nov 25;23(22):4603-7. doi: 10.1093/nar/23.22.4603.
7
erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
Br J Cancer. 1994 Nov;70(5):819-25. doi: 10.1038/bjc.1994.405.
8
Antisense DNA and RNA strategies: new approaches to therapy.
J R Coll Physicians Lond. 1994 Nov-Dec;28(6):507-11.
9
Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression.
Br J Cancer. 1995 Mar;71(3):429-37. doi: 10.1038/bjc.1995.88.
10
Human cell lines as models for multidrug resistance in solid tumours.
Cytotechnology. 1993;12(1-3):231-56. doi: 10.1007/BF00744666.
本文引用的文献
1
Inhibition of rabbit beta-globin synthesis by complementary oligonucleotides: identification of mRNA sites sensitive to inhibition.
Arch Biochem Biophys. 1988 Jun;263(2):401-9. doi: 10.1016/0003-9861(88)90652-2.
2
Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.
Science. 1988 Jul 22;241(4864):456-9. doi: 10.1126/science.3293213.
3
Oligodeoxynucleotides as inhibitors of gene expression: a review.
Cancer Res. 1988 May 15;48(10):2659-68.
4
An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.
Mol Cell Biol. 1988 Feb;8(2):963-73. doi: 10.1128/mcb.8.2.963-973.1988.
5
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.
Proc Natl Acad Sci U S A. 1988 Feb;85(4):1028-32. doi: 10.1073/pnas.85.4.1028.
6
Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis.
Curr Top Microbiol Immunol. 1988;141:282-9. doi: 10.1007/978-3-642-74006-0_38.
7
Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones.
J Exp Med. 1988 Dec 1;168(6):2309-18. doi: 10.1084/jem.168.6.2309.
8
Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin.
Science. 1988 Jun 10;240(4858):1544-6. doi: 10.1126/science.2897717.
9
pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs.
Cancer Res. 1986 Jul;46(7):3431-5.
10
Phosphorothioate and normal oligodeoxyribonucleotides with 5'-linked acridine: characterization and preliminary kinetics of cellular uptake.
Gene. 1988 Dec 10;72(1-2):333-41. doi: 10.1016/0378-1119(88)90160-6.
Zotero 插件